Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study

Summary

This study is an open-labeled dose escalating trial in which a total of 32 subjects will receive one of four intranasal rFla-MBP vaccine doses.

Timeline

Start

2005-07

Primary completion

2006-11

Completion

2006-11

Outcome

Outcome not reported

Stopped: “Sponsor”

Drugs

Indications